“Placebo-Controlled Trial of Pharmaceutical Optimized Hydralazine 25mg (F-6) in Patients With Essential Hypertension”. 2024. Medical Forum Monthly 30 (5). https://medicalforummonthly.com/index.php/mfm/article/view/3666.